Recent discussions on X about Lam Research Corporation (LRCX) have centered on a notable downgrade by a major financial institution, sparking a flurry of reactions among investors. Posts on the platform highlight a shift in analyst sentiment, with some expressing concern over projected slowdowns in growth drivers like China and NAND technology for 2026. The conversation remains active as users debate the implications of a lowered price target and whether this signals broader challenges for the semiconductor equipment sector.
Amidst the concern, there are also voices on X pointing to potential upsides, with some highlighting positive technical setups and price target increases from other analysts as reasons for optimism. The stock’s recent price movements and market positioning are frequently mentioned, with users analyzing whether current levels represent a strategic entry point. This mix of perspectives keeps the dialogue engaging, as the community grapples with contrasting views on the company’s near-term trajectory.
Note: This discussion summary was generated from an AI condensation of post data.
Lam Research Corporation Congressional Stock Trading
Members of Congress have traded $LRCX stock 14 times in the past 6 months. Of those trades, 5 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $LRCX stock by members of Congress over the last 6 months:
- SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 08/28.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/07 and 0 sales.
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/18.
- SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/13 and 1 sale worth up to $100,000 on 04/08.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $100,000 on 03/31 and 2 sales worth up to $100,000 on 05/12, 04/07.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 04/16.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 04/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Lam Research Corporation Insider Trading Activity
Lam Research Corporation insiders have traded $LRCX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LRCX stock by insiders over the last 6 months:
- AVA HARTER (Chief Legal Officer) purchased 9 shares for an estimated $601
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Lam Research Corporation Hedge Fund Activity
We have seen 16 institutional investors add shares of Lam Research Corporation stock to their portfolio, and 73 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DNB ASSET MANAGEMENT AS removed 2,574,059 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $250,558,903
- KOVITZ INVESTMENT GROUP PARTNERS, LLC removed 1,337,822 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $97,259,659
- MENORA MIVTACHIM HOLDINGS LTD. removed 1,059,280 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $103,110,315
- MIVTACHIM THE WORKERS SOCIAL INSURANCE FUND LTD. (UNDER SPECIAL MANAGEMENT) removed 113,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,215,100
- INSIGHT WEALTH STRATEGIES, LLC removed 103,703 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,539,208
- VINVA INVESTMENT MANAGEMENT LTD removed 101,156 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,354,041
- CIBC WORLD MARKETS CORP added 97,296 shares (+62.8%) to their portfolio in Q2 2025, for an estimated $9,470,792
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Lam Research Corporation Analyst Ratings
Wall Street analysts have issued reports on $LRCX in the last several months. We have seen 16 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 09/02/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/21/2025
- Citigroup issued a "Buy" rating on 08/01/2025
- Mizuho issued a "Outperform" rating on 08/01/2025
- Argus Research issued a "Buy" rating on 08/01/2025
- Stifel issued a "Buy" rating on 07/31/2025
- Raymond James issued a "Outperform" rating on 07/31/2025
To track analyst ratings and price targets for Lam Research Corporation, check out Quiver Quantitative's $LRCX forecast page.
Lam Research Corporation Price Targets
Multiple analysts have issued price targets for $LRCX recently. We have seen 22 analysts offer price targets for $LRCX in the last 6 months, with a median target of $114.0.
Here are some recent targets:
- Joseph Moore from Morgan Stanley set a target price of $92.0 on 09/02/2025
- C.J. Muse from Cantor Fitzgerald set a target price of $120.0 on 08/21/2025
- Vijay Rakesh from Mizuho set a target price of $120.0 on 08/01/2025
- Jim Kelleher from Argus Research set a target price of $120.0 on 08/01/2025
- Atif Malik from Citigroup set a target price of $113.0 on 08/01/2025
- Charles Shi from Needham set a target price of $115.0 on 07/31/2025
- Ed Yang from Oppenheimer set a target price of $120.0 on 07/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
